🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 6 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
28/11/1977 0,0113 USD
29/08/1977 0,0099 USD
31/05/1977 0,0099 USD
01/03/1977 0,0099 USD
30/11/1976 0,0099 USD
30/08/1976 0,0093 USD
01/06/1976 0,0093 USD
02/03/1976 0,0093 USD
01/12/1975 0,0093 USD
29/08/1975 0,0093 USD
02/06/1975 0,0093 USD
03/03/1975 0,0093 USD
30/08/1974 0,0093 USD
03/06/1974 0,0093 USD
04/03/1974 0,0093 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
28/02/1996 31,49 31,97 31,37 31,43 +1,15% 1,89% 6.485.024
27/02/1996 31,49 31,73 30,77 31,07 -1,14% 3,03% 7.993.934
26/02/1996 31,97 31,97 31,43 31,43 -2,04% 1,68% 5.593.176
23/02/1996 32,38 32,62 31,91 32,08 +0,00% 2,21% 6.970.877
22/02/1996 31,91 32,32 31,61 32,08 +0,75% 2,24% 8.247.550
21/02/1996 31,79 32,14 31,67 31,85 +0,38% 1,50% 9.319.026
20/02/1996 31,49 32,20 31,49 31,73 -3,27% 2,27% 8.412.296
16/02/1996 33,04 33,34 32,62 32,80 -1,26% 2,17% 6.910.093
15/02/1996 33,75 33,75 33,22 33,22 -1,42% 1,59% 4.706.778
14/02/1996 33,52 33,81 33,40 33,70 +0,36% 1,25% 5.652.283
13/02/1996 33,46 33,93 33,46 33,58 -0,35% 1,43% 5.969.198
12/02/1996 33,58 34,05 33,52 33,70 +0,89% 1,60% 4.667.792
09/02/1996 33,04 33,87 33,04 33,40 +0,00% 2,53% 6.495.714
08/02/1996 32,98 33,58 32,74 33,40 +1,45% 2,53% 6.168.738
07/02/1996 32,14 32,98 32,08 32,92 +2,41% 2,78% 6.241.469
06/02/1996 32,44 32,56 32,03 32,14 -2,53% 1,65% 7.672.827
05/02/1996 32,68 32,98 32,56 32,98 -0,36% 1,28% 4.630.064
02/02/1996 33,22 33,46 32,92 33,10 -0,89% 1,62% 3.817.235
01/02/1996 33,22 33,46 33,22 33,40 -0,18% 0,72% 3.312.938
31/01/1996 33,34 33,58 33,22 33,46 +0,00% 1,07% 4.661.504
30/01/1996 32,92 33,52 32,86 33,46 +1,81% 1,99% 7.979.682
29/01/1996 32,92 33,04 32,62 32,86 +1,47% 1,27% 5.582.067
26/01/1996 31,73 32,56 31,67 32,38 +1,50% 2,82% 4.635.304
25/01/1996 32,26 32,32 31,85 31,91 -1,47% 1,48% 5.164.125
24/01/1996 32,08 32,50 32,08 32,38 +1,50% 1,30% 6.079.658
23/01/1996 31,73 31,97 31,49 31,91 +0,94% 1,50% 5.574.941
22/01/1996 31,13 31,85 31,01 31,61 +1,14% 2,68% 5.967.731
19/01/1996 31,13 31,25 31,07 31,25 +0,38% 0,57% 6.136.250
18/01/1996 31,25 31,25 30,95 31,13 -0,38% 0,95% 5.435.347
17/01/1996 31,01 31,43 31,01 31,25 +1,16% 1,35% 6.983.872